Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HA35 Injection for Neuropathic Pain
NCT05809700Completed
- Sponsor
- Dove Medical Press
- Start
- Jun 2023
- Primary completion
- Jul 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of ha35 in neuropathic pain and herpes zoster (HZ), sponsored by Dove Medical Press. Primary endpoints: Numerical Pain Rating Scale and General Comfort Questionnaire at 24 hours. Started Jun 2023; status: completed.
02
Drugs
ha35
03
Conditions
neuropathic painherpes zoster (HZ)
Beyond the preview
Go deeper on NCT05809700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05809700.